6 | | NTF3 | 'human cytomegalovirus (Towne strain)' vs 'none' | infect | RNAseq of proneural glioblastoma stem-like cells 72 hours after infection with human cytomegalovirus (CMV) Towne strain |
-5.4 | | NTF3 | 'HER2 Positive Breast Carcinoma; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
-5.4 | | NTF3 | 'liver tumor' vs 'adjacent non-tumor tissue' | clinical information | Transcriptome sequencing of human hepatocellular carcinoma |
4.9 | | NTF3 | 'astrocyte overexpressing 7 genes' vs 'glioblastoma cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
-4.8 | | NTF3 | 'SOX2 overexpression' vs 'wild type' in 'U-2982' | cell line, phenotype | RNA-seq of human glioblastoma cell lines with overexpression of SOX2, SFRP2 |
4.6 | | NTF3 | 'doxycycline; 0.5 microgram per milliliter; Day 1 post Neurogenin induction' vs 'control' | compound, treatment | Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
-4.3 | | NTF3 | 'tumor' vs 'paratumoral tissue' | clinical information | Transcriptomic characterization of Hepatocellular Carcinoma with CTNNB1 mutation |
-4.2 | | NTF3 | 'tumor necrosis factor alpha' vs 'none' in 'brain microvascular endothelial cell; co-culture' | cell type, growth condition, stimulus | Reactive astrocytes transduce blood-brain barrier inflammation through a TNFα-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin |
-4.1 | | NTF3 | 'non-triple-negative breast cancer; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
4 | | NTF3 | 'aging cells' vs 'spontaneously immortal cells; control' | phenotype, treatment | Pathway Profiling of Replicative and Induced Senescence |
-3.9 | | NTF3 | 'CRISPR-Cas9 induced GNRH1 reporter; 27 day' vs 'wild type genotype; 20 day' | genotype, stimulus, time | RNA-Seq of GNRH1 neurons differentiated from human pluripotent stem cells |
3.9 | | NTF3 | 'astrocyte overexpressing 7 genes' vs 'astrocyte' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
3.7 | | NTF3 | 'young cells' vs 'spontaneously immortal cells; control' | phenotype, treatment | Pathway Profiling of Replicative and Induced Senescence |
-3.7 | | NTF3 | 'P0 cells' vs 'untreated P4 cells' | passage, treatment | Transcription profiling by high throughput sequencing of human fetal differentiated P0 retinal pigment epithelial cells, mesenchymal P4 cells, and A-83-01 rescued P4 cells |
-3.5 | | NTF3 | 'breast carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-3.2 | | NTF3 | 'neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma |
3.1 | | NTF3 | 'dexamethasone; 1 micromolar' vs 'ethanol' | compound | RNA-seq in GR18 cell line to identify genes regulated by the Glucocorticoid Receptor |
3.1 | | NTF3 | 'doxycycline; 0.5 microgram per milliliter; Day 3 post Neurogenin induction' vs 'control' | compound, treatment | Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
3.1 | | NTF3 | 'ochratoxin A; 130 nanomolar' vs 'none' at '1 day' | compound, time | Microarray mRNA data of RPTEC/TERT1 cells exposed to nephrotoxic chemicals ochratoxin A and potassium bromate |
3 | | NTF3 | 'group 3 medulloblastoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
-3 | | NTF3 | 'KLF17 overexpression' at '24 day' vs 'wild type' at '0 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
-2.9 | | NTF3 | 'FiPS generated with GATA3VP16, SOX2vP16, KLF4 and cMYC' vs 'Control fibroblasts' | cell type | Gene expression from human fibroblasts |
2.9 | | NTF3 | 'transduced with HOXA1' vs 'control' | treatment | Gene expression profiling of enforced HOXA1 expression in melanoma cell line |
-2.7 | | NTF3 | 'SNCA overexpression' vs 'wild type genotype' | genotype | RNA-seq of human midbrain organoid models of Parkinson's Disease |
-2.6 | | NTF3 | 'neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | Next Generation Sequencing Identification of HBV-MLL4 integration and its molecular basis in Chinese hepatocellular carcinoma |
2.6 | | NTF3 | 'astrocyte overexpressing 4 genes' vs 'glioblastoma cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
-2.5 | | NTF3 | 'wild type ZFP36L1; 4-hydroxytamoxifen; senescent cell' vs 'wild type non-senescent cell' | compound, genotype, phenotype | Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant |
2.5 | | NTF3 | 'SOX2 siRNA' vs 'negative control' in '2102Ep' | RNA interference, cell line | Gene expression data from SOX2 knock-out 2102Ep and NTera-2 human embryonal carcinoma cell lines |
2.4 | | NTF3 | 'replicatively senescent; grown until growth arrest' vs 'spontaneously immortal cells; control' | phenotype, treatment | Pathway Profiling of Replicative and Induced Senescence |
-2.3 | | NTF3 | 'wild type; 4-hydroxytamoxifen; senescent cell' vs 'wild type non-senescent cell' | compound, genotype, phenotype | Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant |
-2.3 | | NTF3 | '7 hour' vs '0 hour' in 'MDA-LM2' | cell line, time | Transcription profiling by high throughput sequencing in MDA-MB-231 and MDA-LM2 cell lines |
-2.3 | | NTF3 | '24 hours with hMSC Adipogenic Differentiation Bullet Kit' vs 'none' in 'polysome' | fraction, protocol | RNA-seq of total RNA from human adipose tissue stem cells induced to adipogenesis and osteogenesis for 24 hours |
-2.2 | | NTF3 | 'KLF17 overexpression' at '1 day' vs 'wild type' at '0 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
-2.2 | | NTF3 | 'colorectal carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
2.1 | | NTF3 | 'GATA6 R456C/+; Patient A' vs 'wild type genotype; H9' in 'definitive endoderm cell' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
-2.1 | | NTF3 | 'pBABE-puro-H-RasG12V; senescent' vs 'control; proliferative' | genotype, phenotype | Transcription profiling by high throughput sequencing of proliferative and Ras-induced senescent human primary fibroblasts |
-2.1 | | NTF3 | '4-hydroxytamoxifen' vs 'none' in 'scrambled control' | RNA interference, compound | Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence |
-2 | | NTF3 | 'shRNA knockdown of PROX1' vs 'wild type phenotype' in 'U-343_MGa' | cell line, phenotype | RNA-seq analysis of PROX1 overexpression and knockdown in glioblastoma cell lines |
2 | | NTF3 | 'group 4 medulloblastoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
-2 | | NTF3 | 'triple-negative breast cancer; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
-1.9 | | NTF3 | 'inflammatory breast cancer' vs 'normal' | disease | Expression Analysis of Microdissected Inflammatory Breast Cancer |
-1.9 | | NTF3 | 'Braf activated' vs 'untreated' | treatment | Expression data from Control, Uninfected and BRAF infected cells |
-1.9 | | NTF3 | 'induced pluripotent stem cell' vs 'fibroblast of dermis' in 'normal' | cell type, disease | Klinefelter syndrome derived hiPSCs show similar XCI behavior as female hPSCs |
-1.8 | | NTF3 | '4-hydroxytamoxifen' vs 'none' in 'miR-34a LNA inhibitor' | RNA interference, compound | Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence |
1.8 | | NTF3 | '154; 1 micromolar' vs 'DMSO' | compound | Development of a small molecule for treatment of castration resistant prostate cancer via androgen receptor and IL6/STAT3 pathways |
-1.8 | | NTF3 | 'non-inflammatory breast cancer' vs 'normal' | disease | Expression Analysis of Microdissected Inflammatory Breast Cancer |
-1.8 | | NTF3 | '10 unit per milliliter; JFHA' vs 'control' | compound | Primary human hepatocytes treated with IL28B and the HCV JFH1 Genotype 2A clone. |
-1.8 | | NTF3 | 'Down syndrome' vs 'normal' | disease | RNA-seq of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 |
-1.8 | | NTF3 | 'tumor necrosis factor alpha' vs 'none' in 'brain microvascular endothelial cell; monoculture' | cell type, growth condition, stimulus | Reactive astrocytes transduce blood-brain barrier inflammation through a TNFα-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin |
1.8 | | NTF3 | 'NSAID-exacerbated respiratory disease' vs 'normal' | disease | Total RNAseq of human healthy control inferior turbinate and glucocorticoid-treated, NSAID-exacerbated respiratory disease (N-ERD) nasal polyp nasal brushings |
1.7 | | NTF3 | '3 to 5 weeks post ovulation' vs 'adult' in 'normal' | developmental stage, disease | Comparison of gene expression profiling of human lung at four developmental stages and lung adenocarcioma |
1.7 | | NTF3 | 'Numb5 overexpression' vs 'control' in 'MDAMB231' | cell line, genotype | Expression profile of MDA-MB-231 and MCF7 cells stably transfected with GFP-Numb4, GFP-Numb5, GFP-Numb6 |
1.7 | | NTF3 | 'CLF1' vs 'CLS1; co-culture with CAF to generate sphere' | cell line, growth condition, passage | Cancer-Associated Fibroblasts Support Lung Cancer Stemness through Paracrine IGF-II/IGF1R/Nanog Signaling |
-1.7 | | NTF3 | 'gefitinib; 24 hour' vs 'none; 2 hour' | compound, time | RNA-seq of A431 cell line after gefitinib treatment |
1.7 | | NTF3 | 'valproic acid; 15 millimolar' vs 'control' at '3 day' | compound, sampling time point | RNA-seq of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout. |
1.7 | | NTF3 | 'post full confluence' vs 'early cell adhesion' | sampling time point | Transcription profiling by array of human osteogenic cells at different stages of the differentiation process |
1.7 | | NTF3 | 'astrocyte overexpressing 4 genes' vs 'astrocyte' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
-1.6 | | NTF3 | '11 day' vs '0 day' | time | RNA-Seq characterization of human H1-derived NPC differentiation timecourse |
1.6 | | NTF3 | 'AD80; 0.05 micromolar' vs 'vehicle' in 'HuH-7' | cell line, compound | RNA-seq of human hepatocellular carcinoma cell line Huh7 and immortalized hepatocyte cell line THLE5B treated with experimental compound AD80, Sorafenib, and vehicle for 24 hours |
1.6 | | NTF3 | 'Numb6 overexpression' vs 'control' in 'MDAMB231' | cell line, genotype | Expression profile of MDA-MB-231 and MCF7 cells stably transfected with GFP-Numb4, GFP-Numb5, GFP-Numb6 |
1.6 | | NTF3 | '5 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.6 | | NTF3 | 'medulloblastoma' vs 'normal' | disease | Expression data from human brain tumors and human normal brain |
1.6 | | NTF3 | 'sodium metavanadate' vs 'control' | compound | Sodium metavanadate exhibits carcinogenic tendencies in vitro in immortalized human bronchial epithelial cells [DEG.C] |
1.5 | | NTF3 | 'blood alcohol content 0.04%rising' vs 'control' in 'time point 2' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.5 | | NTF3 | 'heat shock' vs 'untreated' | growth condition | RNA-seq analysis of U2OS cells exposed to heat stress |
1.5 | | NTF3 | '6 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.5 | | NTF3 | 'BT20; 24 hour' vs 'BT20; 0 hour' | cell line, time | Transcription profiling by array of triple-negative, HER2-overexpressing and hormone-sensitive breast carcinoma cell lines after EGFR inhibition with erlotinib |
1.5 | | NTF3 | 'astrocyte overexpressing 7 genes' vs 'glioma stem cell line' | phenotype | Transcription profiling by array of human primary astrocytes, cancer stem cells derived from astrocytes overexpressing various oncogenic and iPSC-inducing factors, glioma stem cells and gliblastomat cell line to compare their expression profiles and tumor-initiating capabilities |
1.5 | | NTF3 | 'Ataxia-telangiectasia' vs 'normal' in 'neural stem cell' | cell type, disease | Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks |
1.5 | | NTF3 | 'KLF17 overexpression' at '5 day' vs 'wild type' at '0 day' | phenotype, time | RNA-seq of hESCs undergoing primed to naive-like resetting via exogenous KLF17 overexpression |
1.4 | | NTF3 | 'blood alcohol content 0.02%declining' vs 'control' in 'time point 5' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.4 | | NTF3 | 'embryonic stem cell differentiating toward definitive endoderm; 36 hour' vs 'embryonic stem cell; 0 hour' | cell type, time | RNA-seq of definitive endoderm differentiation of human embryonic stem cells in early G1 phase of the cell cycle |
-1.4 | | NTF3 | 'Braf activated' vs 'empty vector' | treatment | Expression data from Control, Uninfected and BRAF infected cells |
1.4 | | NTF3 | '7 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.4 | | NTF3 | 'medulloblastoma' vs 'normal' | disease | Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes |
-1.4 | | NTF3 | 'RXF 393; poorly differentiated hypernephroma; P10' vs 'RXF 393; poorly differentiated hypernephroma; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
1.4 | | NTF3 | 'breast cancer' vs 'normal' | disease | Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast |
-1.3 | | NTF3 | 'psoriasis; lesional skin' vs 'normal; normal' | disease, phenotype | Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms |
1.3 | | NTF3 | 'blood alcohol content 0%' vs 'control' in 'time point 1' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.3 | | NTF3 | 'HNF4a homozygous deletion mutant (DBD Mut)' vs 'wild type' | genetic modification | Transcriptomic profiling of mutant and WT HNF4alpha hepatic progenitor stage cells |
-1.3 | | NTF3 | '2 micromolar retinoic acid' vs 'none' | compound | Transcription profiling by array of human embryonic stem cells response to retinoic acid exposure |
-1.3 | | NTF3 | 'MCT8[P321L]' vs 'correction to MCT8[wt]' in 'derived brain microvascular endothelial cell' | cell type, compound, genotype | RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells |
1.3 | | NTF3 | '9 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
1.3 | | NTF3 | 'sonic hedgehog group medulloblastoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
-1.3 | | NTF3 | 'induced pluripotent stem cell' vs 'fibroblast of dermis' in 'Klinefelter's syndrome' | cell type, disease | Klinefelter syndrome derived hiPSCs show similar XCI behavior as female hPSCs |
-1.2 | | NTF3 | 'progenitor cell of endocrine pancreas' vs 'definitive endoderm cell' in 'GATA6 R456C/+; Patient A" | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
1.2 | | NTF3 | 'blood alcohol content 0.08%' vs 'control' in 'time point 3' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.2 | | NTF3 | 'blood alcohol content 0.04%declining' vs 'control' in 'time point 4' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.2 | | NTF3 | 'recombinant human MFAP5 protein' vs 'vehicle control' | compound | Expression analysis on microfibrillar associated protein 5 (MFAP5) protein treated ovarian cancer cell line OVCA432 |
-1.2 | | NTF3 | '2 micromolar; retinoic acid' vs '1 micromolar DMSO' | compound | Transcription profiling by array of human embryonic stem cells response to retinoic acid exposure |
1.2 | | NTF3 | '4 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.2 | | NTF3 | 'paediatric' vs 'foetal' in 'epithelial cell of large intestine' | cell type, developmental stage | Transcriptional profiling by array of intestinal epithelial cells from foetal and paediatric gut |
1.2 | | NTF3 | 'Human betacoronavirus 2c England-Qatar/2012; 24 hour' vs 'mock; 18 hour' | infect, time | Transcription profiling of human bronchial epithelial cell line Calu-3 2B4 infected with Human Coronavirus MERS-CoV-London |
1.2 | | NTF3 | 'ovarian cancer' vs 'normal' in 'epithelial cell' | cell type, disease | A cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer |
-1.2 | | NTF3 | 'expression of wild type RBM47' vs 'empty vector' | genotype | Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression |
1.2 | | NTF3 | 'Neurobasal medium' vs 'DMEM/F12 with glutamax' | growth condition | RNA sequencing of human iPSC-derived brain microvascular endothelial cells. |
-1.2 | | NTF3 | 'high guluronic acid alginate' vs 'monolayer' | growth condition | Transcription profiling by array of human mesenchymal stem cells in 2D culture compared with two different alginate-based 3D scaffolds |
-1.1 | | NTF3 | 'lesion' vs 'normal tissue adjacent to lesion' in '1 week' | sampling site, time | RNA-sequencing of the mRNA transcriptome in lesional and non-lesional skin, across three time-points in severe psoriasis patients treated with the tumor necrosis factor (TNF) inhibitor, etanercept |
1.1 | | NTF3 | '6 to 8 weeks post ovulation' vs 'adult' in 'normal' | developmental stage, disease | Comparison of gene expression profiling of human lung at four developmental stages and lung adenocarcioma |
1.1 | | NTF3 | 'DISC1 exon 2 mut/mut' vs 'wild type' in 'neural progenitor cell' at 'embryoid body, day 17' | cell type, genotype, sampling time point | Transcriptome profiling of human neural progenitor cells and neurons with DISC1 interruption |
-1.1 | | NTF3 | 'papillary renal cell carcinoma' vs 'normal' in 'adult' | developmental stage, disease | Gene expression data from human data of different types of renal tumors and normal kidneys |
-1.1 | | NTF3 | 'GATA6 R456C/+; Patient A' vs 'wild type genotype; H9' in 'progenitor cell of endocrine pancreas' | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
-1.1 | | NTF3 | 'tuberculin' vs 'saline' | stimulus | Transcriptional profiling of the tuberculin skin test in individuals cured of active tuberculosis disease (RNA-Seq) |
1.1 | | NTF3 | '8 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1.1 | | NTF3 | 'ETP-45658' vs 'DMSO' | compound | Gene expression profiling upon PI3K inhibition using different inhibitors |
-1.1 | | NTF3 | 'chronic discoid lupus erythematosus' vs 'normal' | clinical history | Gene expression in cutaneous lupus erythematosus |
-1.1 | | NTF3 | 'pBABE-puro-H-RasG12V transfected' vs 'control' | genotype | Transcription profiling by array of Ras-induced human fibroblast cell line WI38 to analyse transcriptional changes in senescent cells |
1.1 | | NTF3 | 'Bmi1 knockdown' vs 'control' | compound, genotype, time | Transcription profiling by array of human multiple myeloma cells after infection with a shRNA targeting BMI1 |
-1.1 | | NTF3 | 'NiO nanoparticles; 0.5 microgram per milliliter' vs 'none' | compound | RNA-Seq of BEAS-2B cells treated with low doses of Ni and NiO nanoparticles as well as NiCl2 for 6 weeks |
-1.1 | | NTF3 | 'esophageal adenocarcinoma' vs 'normal' | disease, disease staging | Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's |
1.1 | | NTF3 | 'Tetralogy of Fallot' vs 'normal' | disease | RNA-seq of heart right ventricle from 22 patients with Tetralogy of Fallot and healthy individuals |
1.1 | | NTF3 | 'non primary Sjogren syndrome sicca' vs 'normal' | block, disease | Transcription profiling by array of parotid tissue from Primary Sjögren’s Syndrome and controls |
1.1 | | NTF3 | 'EPZ004777; 6.4 micromolar' vs 'dimethyl sulfoxide; 1E-08 molar' in 'PEO4' | cell line, compound | Functional effect of DOT1L pharmacological inhibition in ERα-positive Ovarian Cancer cells |
1.1 | | NTF3 | 'p63 knockdown by siRNA' vs 'scrambled siRNA' in 'BxPC-3' | RNA interference, cell line | RNA-seq of human pancreatic cell lines, L3.6pl and BxPC-3, upon knockdown of p63 for 48 hours compared to siControl |
-1.1 | | NTF3 | 'brain-derived neurotrophic factor' vs 'none' at '2 hour' | sampling time point, stimulus | RNA-seq of human neurons derived from H9 embryonic stem cell lines treated with BDNF, TrkB agonist ZEB 85 or NT4 against untreated controls |
1.1 | | NTF3 | 'DISC1 exon 8 mut/mut' vs 'wild type' in 'neuron' at 'embryoid body, day 50' | cell type, genotype, sampling time point | Transcriptome profiling of human neural progenitor cells and neurons with DISC1 interruption |
-1 | | NTF3 | 'HFF1; cocultured with epithelial Cal51 cells' vs 'HFF1; normal' | cell line, growth condition | System-Wide Analysis Reveals a Complex Network of Tumor-Fibroblast Interactions Involved in Tumorigenicity |
-1 | | NTF3 | 'HFFF2; cocultured with epithelial MDAMB231 cells' vs 'HFFF2; normal' | cell line, growth condition | System-Wide Analysis Reveals a Complex Network of Tumor-Fibroblast Interactions Involved in Tumorigenicity |
1 | | NTF3 | 'MDAMB231; cocultured with fibroblast Wi38' vs 'MDAMB231; normal' | cell line, growth condition | System-Wide Analysis Reveals a Complex Network of Tumor-Fibroblast Interactions Involved in Tumorigenicity |
1 | | NTF3 | 'ICI 182,780; 1E-08 molar' vs 'dimethyl sulfoxide; 1E-08 molar' in 'PEO1' | cell line, compound | Functional effect of DOT1L pharmacological inhibition in ERα-positive Ovarian Cancer cells |
1 | | NTF3 | 'liver hemangioma' vs 'normal' | disease | Integrated ordination of miRNA and mRNA expression profiles [mRNA] |
1 | | NTF3 | 'KLF17 overexpression' vs 'wild type phenotype' at '4 day' | phenotype, time | RNA-seq of hESCs overexpressing inducible KLF17 versus uninduced controls. |
-1 | | NTF3 | 'cisplatin; 100 micromolar' vs 'none' in 'TMEM45A knockdown by siRNA' | RNA interference, compound | RNA-seq of human head and neck cancer cell line SQD9 knock-out for TMEM45A exposed to cisplatin |
1 | | NTF3 | 'SOX2 siRNA' vs 'negative control' in 'NTera-2' | RNA interference, cell line | Gene expression data from SOX2 knock-out 2102Ep and NTera-2 human embryonal carcinoma cell lines |
-1 | | NTF3 | 'cisplatin; 100 micromolar' vs 'none' in 'scrambled siRNA' | RNA interference, compound | RNA-seq of human head and neck cancer cell line SQD9 knock-out for TMEM45A exposed to cisplatin |
1 | | NTF3 | 'KLF17 overexpression' vs 'wild type phenotype' at '3 day' | phenotype, time | RNA-seq of hESCs overexpressing inducible KLF17 versus uninduced controls. |
-1 | | NTF3 | 'PI-103' vs 'DMSO' | compound | Gene expression profiling upon PI3K inhibition using different inhibitors |
1 | | NTF3 | '10 day' vs '0 day' | time | Global expression profiling time series of early human embryonic stem cell differentiation towards the mesoderm lineage |
-1 | | NTF3 | 'neoplasm; malignant' vs 'normal tissue adjacent to neoplasm; non-malignant' in 'hepatocyte' | cell type, phenotype, sampling site | Viral Expression and Molecular Profiling in Liver Tissue versus Microdissected Hepatocytes in Hepatitis B Virus - Associated Hepatocellular Carcinoma |
1 | | NTF3 | 'MDA-MB-231; docetaxel resistant' vs 'MDA-MB-231; control' | cell line, phenotype | Transcription profiling by array of MCF-7 and MDA-MB-213 cells treated with docetaxel |
-1 | | NTF3 | 'DAOY M2.1; MYC overexpression' vs 'DAOY; wild type' | cell type, genotype | Bone morphogenetic protein-7 is a MYC target with pro-survival functions in childhood medulloblastoma |
-1 | | NTF3 | 'not-inflamed; interstitial cystitis' vs 'normal' | clinical information, disease | Transcription profiling by array of bladder tissue of patients with interstitial cystitis |
-1 | | NTF3 | 'TDP-43 knock-down' vs 'control' | genotype | 3'-end targeted sequencing of 6 control and 6 TDP-43 KD samples in HEK293 |
1 | | NTF3 | 'hypoxia' vs 'normoxia' in 'SNF96.2' | cell line, growth condition | Hypoxia and Intrinsic Transcriptomic Subtyping of Soft Tissue Sarcoma |
-1 | | NTF3 | 'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis B virus induced hepatocellular carcinoma' | clinical information, disease | Transcription profiling by array of human hepatitis B virus (HBV) and hepatitis C virus (HCV) induced hepatocellular (HCC) carcinoma and surrounding noncancerous liver tissue. |
-1 | | NTF3 | 'epithelial cell of small intestine' vs 'epithelial cell of large intestine' in 'foetal' | cell type, developmental stage | Transcriptional profiling by array of intestinal epithelial cells from foetal and paediatric gut |
-1 | | NTF3 | 'tripeptide arginine-glycine-aspartic acid-modified alginate' vs 'monolayer' | growth condition | Transcription profiling by array of human mesenchymal stem cells in 2D culture compared with two different alginate-based 3D scaffolds |
-1 | | NTF3 | 'cultured with 3D BPH-1 epithelial acini' vs 'cultured without epithelial acini' | growth condition | Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells |
